@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
sub:assertion prov:wasGeneratedBy "S&T TWOC project version 1" .
sub:version prov:value "1"^^xsd:integer .
rdf:object ns2:C0015283 "exocytosis";
ns2:C1184743 "process";
ns2:C1522240 "process";
ns2:C4521541 "process" .
rdf:predicate ns3:TRIPLE_UID:d6xcjtu8-TRIPLE-ABSTRACT-2 "inhibit" .
rdf:subject ns2:C0011777 "dexamethasone" .
rdfs:Triple-UID ns1:TRIPLE_UID:d6xcjtu8-TRIPLE-ABSTRACT-2 "d6xcjtu8-TRIPLE-ABSTRACT-2" .
rdfs:sentence rdfs:label "In our previous basic studies, anti-allergic drugs (olopatadine, ketotifen), antibiotics (clarithromycin) and corticosteroids (hydrocortisone, dexamethasone) inhibited the process of exocytosis and showed anti-allergic drugs (olopatadine, ketotifen), antibiotics (clarithromycin) and corticosteroids (hydrocortisone, dexamethasone)'s potency as highly effective mast cell stabilizers." .
rdfs:triple rdfs:label "dexamethasone ) inhibited the process of exocytosis" .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-07-25T21:47:35.599182"^^xsd:dateTime .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "QJCT5wtM+UYxMg/vV5IKQC1yrSLtA8ZG1Adaz21t8QBzt0AMo+k3SEQYgoOd5rTfGdPUrJc557ZhiWZoyU2+pCSEseWoi50ehkDiOhQV+kl1BAdbFCQpphwj60y+1wOoEZ2VCcoOlTMs70ia+dSBngzQbY7AROzaskg75B5v2O0=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-07-25T21:47:35.599182"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}